- Home
- ANIX vs CHMI Comparison
ANIX vs CHMI Comparison
Compare ANIX & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- CHMI
- Stock Information
- Founded
- ANIX 1982
- CHMI 2012
- Country
- ANIX United States
- CHMI United States
- Employees
- ANIX N/A
- CHMI N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- CHMI Real Estate Investment Trusts
- Sector
- ANIX Health Care
- CHMI Real Estate
- Exchange
- ANIX Nasdaq
- CHMI Nasdaq
- Market Cap
- ANIX 101.4M
- CHMI 97.2M
- IPO Year
- ANIX 1987
- CHMI 2013
- Fundamental
- Price
- ANIX $3.08
- CHMI $2.73
- Analyst Decision
- ANIX Strong Buy
- CHMI Buy
- Analyst Count
- ANIX 2
- CHMI 2
- Target Price
- ANIX $8.50
- CHMI $5.00
- AVG Volume (30 Days)
- ANIX 128.3K
- CHMI 235.2K
- Earning Date
- ANIX 01-14-2025
- CHMI 11-12-2024
- Dividend Yield
- ANIX N/A
- CHMI 21.98%
- EPS Growth
- ANIX N/A
- CHMI N/A
- EPS
- ANIX N/A
- CHMI N/A
- Revenue
- ANIX N/A
- CHMI N/A
- Revenue This Year
- ANIX N/A
- CHMI N/A
- Revenue Next Year
- ANIX N/A
- CHMI $12.15
- P/E Ratio
- ANIX N/A
- CHMI N/A
- Revenue Growth
- ANIX N/A
- CHMI N/A
- 52 Week Low
- ANIX $2.15
- CHMI $2.71
- 52 Week High
- ANIX $5.13
- CHMI $4.39
- Technical
- Relative Strength Index (RSI)
- ANIX 42.34
- CHMI 13.96
- Support Level
- ANIX $3.07
- CHMI $3.21
- Resistance Level
- ANIX $4.20
- CHMI $3.30
- Average True Range (ATR)
- ANIX 0.30
- CHMI 0.10
- MACD
- ANIX -0.06
- CHMI -0.05
- Stochastic Oscillator
- ANIX 2.61
- CHMI 2.86
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.